Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations

BJU Int. 2015 Apr;115(4):500. doi: 10.1111/bju.12966.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / blood*
  • Humans
  • Kallikreins / blood*
  • Male
  • Men's Health*
  • Prostate / pathology*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology
  • Severity of Illness Index

Substances

  • Biomarkers, Tumor
  • Kallikreins
  • kallikrein-related peptidase 3, human
  • Prostate-Specific Antigen